WHO Drug Versioning

As new versions of WHO Drug are released, keeping your company up-to-date can be a constant struggle.

ThesIS offers an innovative versioning service that can migrate ("upversion") your entire company to the latest release quickly and cost-effectively. We make it easy to continually keep your company up-to-date as new WHO Drug versions are released.

Our WHO Drug versioning service is available for any WHO Drug format (B1, B2 or C) and is not limited to the latest WHO Drug version. We can migrate you from and to any WHO Drug version.

Exclusive WHO Drug Versioning Tools

Our proprietary thesaurus system contains innovative WHO Drug versioning tools that enable us to quickly and precisely pinpoint those reported terms that need to be re-coded as a result of the new version.

First, we identify and re-code those reported terms coded to a WHO Drug entry which has subsequently been deleted from the new version.

We then identify and re-code those reported terms for which a newly added entry is a better choice than what was previously available. We accomplish this, however, without the need to evaluate every reported term. Checking every reported term would be extremely laborious and costly, equivalent to a complete re-coding.

Instead, our expert coders use our exclusive versioning tools to apply a top-down process where we take each new drug entry and then identify exactly those reported terms that should be re-coded to that new entry. Our versioning tools contain a powerful search capability that enables us to quickly and accurately pinpoint these reported terms.

Updated Coding for Re-Formulated Drugs

Our coding experts also use our exclusive WHO Drug versioning tools to handle WHO Drug entries where the ingredients, dosage form, and/or strength has changed.

Using the same top-down approach as for new drug entries, our expert coders identify re-formulated drugs within the dictionary and then search your reported terms to quickly and accurately pinpoint those that need to be re-coded.

This top-down approach will identify those reported terms that should be re-coded to the revised drug entry because the the revised entry is a better choice than what was previously available. It will also determine if reported terms previously coded to that drug entry now need to be re-coded because the revised entry is no longer an appropriate choice.

Complete Versioning with Minimal Re-Coding

The end result of this innovative process is that your data is completely updated to the latest version (every reported drug coded to the best possible WHO Drug entry) with minimal re-coding.

This highly targeted approach means that the vast majority of your data remains unchanged, thereby preserving the quality of your original coding.

Updated ATC Code Selections

Changes to the available ATC codes for a WHO Drug entry also need to be applied to your data. We identify those WHO Drug entries where one or more ATC codes have been added or removed.

For each drug entry where your previous ATC choice is no longer available in the new version, we provide you a facility to choose a new ATC code.

For each drug entry where your previous ATC choice is still available in the new version, we provide a facility to assess your previous selection against the choices now available. You can then determine whether you want to keep your previous selection or to make a different selection from the newly available choices.

WHO Drug Versioning Made Simple

With our WHO Drug versioning service, you get more than just comparison reports. You get actual data completely updated to the new version. You will have data coded to both the new and old versions, allowing you to report against either version.

ThesIS's versioning techniques and proprietary tools are the culmination of our many years of experience. We provide a simple and cost-effective way to keep your data up-to-date with WHO Drug.

HomeTerms of UsePrivacy PolicyUseful Links | Site MapWebmaster

ThesIS and the ThesIS logo are service marks of Thesaurus Information and Strategies, Inc.
MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers Association (IFPMA).

Copyright © 2002-2011.  Thesaurus Information and Strategies, Inc.  All Rights Reserved.